Daniel Chevallard

Daniel Chevallard

Chief Financial OfficeratLENZ Therapeutics· In the 2024 proxy

Pay in FY2024LENZ Therapeutics stock +132.8% the same year

Daniel Chevallard was paid $3.1M in FY2024 (Dec). LENZ Therapeutics stock rose 132.8% that year.

Pay$100 in the stock at the end of FY23 → $233
Pay is from the Summary Compensation Table of each LENZ Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. LENZ TherapeuticsPublic company · 2 yr
    • Chief Financial Officer2024 – Present · 2 yrStock in role -72%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?